Sponsor Perspective: Alexion Pharmaceuticals | Rare Disease Day: 40 Years of the Orphan Drug Act - YouTube
AstraZeneca buys rare disease drugmaker Caelum in potential $500 mln deal | Reuters
Alexion Receives FDA Approval for New Advanced Formulation of ULTOMIRIS® (ravulizumab-cwvz) with Significantly Reduced Infusion Time | BioSpace
Alexion to Acquire Achillion | Business Wire
Alexion moving to Boston but keeping 450 workers in New Haven
File:Alexion Pharmaceuticals logo.svg - Wikipedia
Alexion Pharma to pay $21 million fine for paying bribes in Russia and Turkey - Anticorr.media
Alexion Prevent Phase 3 Results - Guthy-Jackson CF
UK regulators to review AstraZeneca's €32bn Alexion buyout - Industry Europe
AstraZeneca acquires US drug developer Alexion in massive $39 billion deal | International Business
Alexion Pharmaceuticals - Crunchbase Company Profile & Funding
Articles about Alexion
CMA investigating AstraZeneca's anticipated £27.6bn buyout of Alexion :: C+D
Alexion | MMA Global
風起雲湧，基因治療更多競爭力！AZ 旗下Alexion 收購LogicBio 增加爭奪籌碼 | GeneOnline News
Alexion Pharmaceuticals, Logo, White background Stock Photo - Alamy
Alexion finally has a buyer – and it's AstraZeneca with $39bn on the table | pharmaphorum
Alexion Pharma - Ireland - Control Equipment Ltd
AstraZeneca to Acquire Alexion – ISPE Boston
AstraZeneca to acquire Alexion for $39B - MassDevice
Alexion Pharmaceuticals invests in New Haven - Yale Daily News
Sep 21, 2020 South San Francisco / CA / USA - Alexion logo at their headquarters in Silicon Valley; Alexion Pharmaceuticals, Inc. develops treatments Stock Photo - Alamy
JPM: Alexion gives an updated look at what AstraZeneca's getting for $39B | Fierce Pharma
File:Alexion Logo.svg - Wikimedia Commons
Alexion - American Bone Health
